Compulsory Licensing & It's Implication on Innovation: A Study of Indian Pharma-Industry

Abstract

One of the most contentious issues surrounding the constantly changing patent rules is mandatory licensing under Section 98 of the Indian Patents Act, which permits the export of protected medications. This study examines patents as a true obstacle to drug accessibility as well as the extent to which compulsory licensing changes the landscape. It does so by referencing the most recent legal development, Natco v. Pfizer, which has brought the key provisions under close scrutiny from the legal community. The goal of this research is to evaluate the problem of patents within the context of the probable verdict in this historic case.